Correlation Between Revolution Medicines and Tcr2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Tcr2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Tcr2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Tcr2 Therapeutics, you can compare the effects of market volatilities on Revolution Medicines and Tcr2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Tcr2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Tcr2 Therapeutics.
Diversification Opportunities for Revolution Medicines and Tcr2 Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Revolution and Tcr2 is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Tcr2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tcr2 Therapeutics and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Tcr2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tcr2 Therapeutics has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Tcr2 Therapeutics go up and down completely randomly.
Pair Corralation between Revolution Medicines and Tcr2 Therapeutics
Given the investment horizon of 90 days Revolution Medicines is expected to generate 1.14 times more return on investment than Tcr2 Therapeutics. However, Revolution Medicines is 1.14 times more volatile than Tcr2 Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Tcr2 Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 2,127 in Revolution Medicines on August 24, 2024 and sell it today you would earn a total of 3,548 from holding Revolution Medicines or generate 166.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 10.36% |
| Values | Daily Returns |
Revolution Medicines vs. Tcr2 Therapeutics
Performance |
| Timeline |
| Revolution Medicines |
| Tcr2 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Revolution Medicines and Tcr2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revolution Medicines and Tcr2 Therapeutics
The main advantage of trading using opposite Revolution Medicines and Tcr2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Tcr2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tcr2 Therapeutics will offset losses from the drop in Tcr2 Therapeutics' long position.| Revolution Medicines vs. Lyra Therapeutics | Revolution Medicines vs. Hookipa Pharma | Revolution Medicines vs. Cingulate Warrants | Revolution Medicines vs. SAB Biotherapeutics |
| Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. Pieris Pharmaceuticals | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |